Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

U-M scientists use 21st-century technology to probe secrets of M. tuberculosis

27.05.2004


Computer model shows why some get sick after TB infection, while others don’t



University of Michigan microbiologists have created a virtual model of the human immune system that runs "in silico" to study what happens inside the lungs after people inhale Mycobacterium tuberculosis, the bacterium that causes TB.

The computer model is helping scientists learn more about this ancient pathogen, and why some people are able to fight off the infection, while others get sick. U-M scientists believe the answer could be hidden inside structures called granulomas, which immune cells build to surround and contain invading M. tuberculosis bacteria.


"Granulomas are the hallmark of tuberculosis," says Denise Kirschner Ph.D., an associate professor of microbiology and immunology in the U-M Medical School. "It’s the immune system’s fail-safe response to infection. If the immune system can’t clear the pathogen, it gets out the masonry and walls it off."

Kirschner presented research results and an analysis of time-lapse computer animations showing granuloma formation at a May 26 seminar during the American Society for Microbiology’s annual meeting held here this week.

"M. tuberculosis has been living with people for at least 4,000 years," says Kirschner. "Because the bug has had all those years to get to know us so well, it has evolved several effective ways to circumvent the immune system’s ability to detect and kill invading pathogens. Scientific knowledge of how the immune system interacts with M. tuberculosis is slowly improving, but we are far from prevention or an effective vaccine. It’s important to understand TB, because the disease is a serious and growing public health problem."

According to Kirschner, approximately 2 billion people worldwide are infected with M. tuberculosis, and the disease kills about 3 million people every year. In the early stages of infection, tuberculosis can be treated with powerful antibiotics, but there is no cure. And multi-drug-resistant strains, which are essentially untreatable, are becoming more common.

The immune system’s immediate response to the presence of M. tuberculosis in the lungs is to surround the bacteria with immune cells called macrophages, which signal other immune cells to join them for a group assault on the invading bacteria, Kirschner says. About 90 percent of the time, these multi-cellular structures called granulomas are enough to stop the bacteria from spreading. Although the individual will always be infected with TB bacteria, the disease will remain in a latent phase and produce no symptoms, unless it flares up again later in life.

Between 5 percent to 10 percent of the time, however, granulomas fail to contain the bacteria. Unless the disease is diagnosed and treated, TB bacteria will continue to spread through the lungs, eventually producing severe respiratory symptoms and death.

Since granulomas are the key counter-offensive in the war between the human host and M. tuberculosis, Kirschner and U-M post-doctoral fellows Jose Segovia-Juarez, Ph.D., and Suman Ganguli, Ph.D., programmed their computer model with experimental data from studies - directed by University of Pittsburgh collaborator Joanne Flynn, Ph.D. - of research animals infected with TB. They then created time-lapse animations demonstrating what happens as a granuloma forms after initial infection with the bacteria.

When they analyzed the results of the computer simulation, Kirschner and her research team found new clues to the immune system’s containment process:

- Granulomas that were unable to contain TB bacteria were packed with inactive macrophages, making it impossible for T cells to get inside the granuloma and properly signal the macrophages to attack and kill M. tuberculosis bacteria. - The arrival time, number and location of "educated" T cells, which had been primed by the immune system to signal macrophages to attack M. tuberculosis, were crucial to the success of the immune response.

- The slow reproduction rate of M. tuberculosis bacteria, which doubles about every two days, helps the bacteria survive undetected inside macrophages for long periods of time.

Mathematical models are a valuable addition to experimental research, because they make it possible to study complex biological systems with many variables in ways that would be impossible in humans or research animals.

"Here we used a new approach called agent-based modeling, which allowed us to track the individual behavior of specific cells in the system and how they contributed to the collective outcome," Kirschner says. "This is one of first applications of this method in studies of infectious diseases within the host."



Kirschner’s research is funded by the National Heart, Lung and Blood Institute of the National Institutes of Health.

Note: Animations of granuloma formation described in this story can be viewed in AVI format on the Web at http://malthus.micro.med.umich.edu/lab/abm/movies/. The first version (clearance.avi) shows what happens to the granuloma when the immune system is able to destroy the bacteria. The second version (containment.avi) shows granuloma formation when infection is contained. The third version (dissemination.avi) shows what happens to the granuloma when the infection is not contained.

Cells are color coded as follows: Inactive macrophages (green), activated macrophages (blue), infected macrophages (orange), chronically infected macrophages (red), T cells (pink), necrotic tissue (brown) and extracellular bacteria (yellow).

Additional Contact:
Kara Gavin, kegavin@umich.edu, 734-764-2220

Sally Pobojewski | EurekAlert!
Further information:
http://malthus.micro.med.umich.edu/lab/abm/movies/

More articles from Health and Medicine:

nachricht Research offers clues for improved influenza vaccine design
09.04.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Injecting gene cocktail into mouse pancreas leads to humanlike tumors
06.04.2018 | University of Texas Health Science Center at San Antonio

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

Im Focus: The Future of Ultrafast Solid-State Physics

In an article that appears in the journal “Review of Modern Physics”, researchers at the Laboratory for Attosecond Physics (LAP) assess the current state of the field of ultrafast physics and consider its implications for future technologies.

Physicists can now control light in both time and space with hitherto unimagined precision. This is particularly true for the ability to generate ultrashort...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Diamond-like carbon is formed differently to what was believed -- machine learning enables development of new model

19.04.2018 | Materials Sciences

Electromagnetic wizardry: Wireless power transfer enhanced by backward signal

19.04.2018 | Physics and Astronomy

Ultrafast electron oscillation and dephasing monitored by attosecond light source

19.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>